Molecules / Fondaparinux / China

Fondaparinux API manufacturers in China

CAS 104993-28-4 ATC B01AX05 Updated 9 July 2026
13
China-based manufacturers with an active filing of 14 worldwide
Showing 7 of 13 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

01

Jiangsu Hengrui Pharmaceuticals

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fondaparinux, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 8 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
8 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

Wisdom Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fondaparinux, filing since 2022. Its 2024 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
03
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for fondaparinux, filing since 2014. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
2 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

BrightGene Bio-Medical Technology

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for fondaparinux, filing since 2016. Its GMP is recognised in 1 market.

US DMF
2 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Newland Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fondaparinux, filing since 2025.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Shanghai Acana Pharmatech

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fondaparinux, filing since 2013.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
07

Sichuan Aupone Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for fondaparinux, filing since 2023.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile

6 more manufacturers in China hold filings for fondaparinux

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Wisdom PharmaceuticalHangzhou Zhongmei Huadong PharmaceuticalBrightGene Bio-Medical TechnologyNewland PharmaceuticalShanghai Acana PharmatechSichuan Aupone Pharmaceutical
Open the full list with a free account

How this list is built

This page filters the worldwide Fondaparinux manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Map fondaparinux for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

All Fondaparinux manufacturers

Worldwide 14